Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Nadia, Howlader"'
Autor:
Nadia Howlader, Elad Sharon, Manami Bhattacharya, Lori A. Ehrlich, Nicholas C. Richardson, Nicole J. Gormley, R. Angelo de Claro, Amy E. Wood, Angela B. Mariotto, Kathleen A. Cronin
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. :OF1-OF4
Introduction: Molecularly targeted therapies such as tyrosine kinase inhibitors (TKI) are effective treatments for B-cell receptor (BCR)-ABL–bearing leukemias. We evaluated the impact of TKIs on historical chronic myeloid leukemia (CML) mortality t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5afd4fb5cc4d0ecff6f9b84959dd3501
https://doi.org/10.1158/1055-9965.epi-22-1171
https://doi.org/10.1158/1055-9965.epi-22-1171
Autor:
Angela B Mariotto, Eric J Feuer, Nadia Howlader, Huann-Sheng Chen, Serban Negoita, Kathy Cronin
Publikováno v:
JNCI: Journal of the National Cancer Institute.
The significant deficit in cancer diagnoses in 2020 due to COVID-19 pandemic disruptions in health care, can pose challenges in the estimation and interpretation of long-term cancer trends. Using SEER (2000-2020) data, we demonstrate that inclusion o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae0d036396ce4544ce72cbffcbdaef08
https://doi.org/10.1093/jnci/djad086
https://doi.org/10.1093/jnci/djad086
Autor:
Kathleen A. Cronin, Angela B. Mariotto, Amy E. Wood, R. Angelo de Claro, Nicole J. Gormley, Nicholas C. Richardson, Lori A. Ehrlich, Manami Bhattacharya, Elad Sharon, Nadia Howlader
Supplementary Figure 1: Trends in Mortality by Leukemia Subtypes and Race Ethnicity. Total US 1992-2018. Results are shown for mortality trends for CML (panel A), ALL (panel B), and CLL (panel C), 1992-2018. For each panel, we show age-adjusted morta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbb286b4d5ecabda426756d34cb6f14
https://doi.org/10.1158/1055-9965.22743779.v1
https://doi.org/10.1158/1055-9965.22743779.v1
Autor:
Kathleen A. Cronin, Angela B. Mariotto, Amy E. Wood, R. Angelo de Claro, Nicole J. Gormley, Nicholas C. Richardson, Lori A. Ehrlich, Manami Bhattacharya, Elad Sharon, Nadia Howlader
Introduction:Molecularly targeted therapies such as tyrosine kinase inhibitors (TKI) are effective treatments for B-cell receptor (BCR)-ABL–bearing leukemias. We evaluated the impact of TKIs on historical chronic myeloid leukemia (CML) mortality tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1608fc95c4bc943532fef93efcac9e5
https://doi.org/10.1158/1055-9965.c.6628385
https://doi.org/10.1158/1055-9965.c.6628385
Adobe PDF - EPI-11-0061R_DeSantis_supp_table_1.pdf from Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad228ae9b8a61f25cf27346a3baf92b4
https://doi.org/10.1158/1055-9965.22435719
https://doi.org/10.1158/1055-9965.22435719
Here we compare estimates of NHL-specific survival (using varying definitions of a cancer-specific (gold standard survival measure from registry data).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7266303fc2c4ead676db6ae9f21bb65b
https://doi.org/10.1158/1055-9965.22436682.v1
https://doi.org/10.1158/1055-9965.22436682.v1
Supplementary Figure 1. Non-Hodgkin Lymphoma (NHL) Death Certificate Mortality and Incidence-based Mortality (IBM) Rates. SEER-9, 1975-2011.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c75d2daef9dabcf25c458b4bcac6d93
https://doi.org/10.1158/1055-9965.22438369.v1
https://doi.org/10.1158/1055-9965.22438369.v1
Autor:
Lynne Penberthy, Valentina I. Petkov, Denise R. Lewis, Nadia Howlader, Sean F. Altekruse, Kathleen A. Cronin, Anne-Michelle Noone
Results from the Joinpoint models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d2a2cdc4c99e56d6345812a8c4d697
https://doi.org/10.1158/1055-9965.22438597.v1
https://doi.org/10.1158/1055-9965.22438597.v1
Supplementary Figure 1 figure legend.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9c2c733d28aa175e5f06fc008bd539
https://doi.org/10.1158/1055-9965.22438372.v1
https://doi.org/10.1158/1055-9965.22438372.v1
Background: Non-Hodgkin lymphoma (NHL) comprises distinct tumor subtypes. Although mortality from NHL overall has changed dramatically in the United States over time, little is known about trends for subtypes, because death certificates do not record
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfcb6ec6efd66436242eeebb2b2b29a2
https://doi.org/10.1158/1055-9965.c.6516334
https://doi.org/10.1158/1055-9965.c.6516334